Lanzhou Institute of Biological Products Co., Ltd
Quick facts
Phase 3 pipeline
- Botulinum Toxin Type A for Injection · Neurology; Dermatology; Aesthetics
Botulinum toxin type A blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Lanzhou Institute of Biological Products Co., Ltd portfolio CI brief
- Lanzhou Institute of Biological Products Co., Ltd pipeline updates RSS
Frequently asked questions about Lanzhou Institute of Biological Products Co., Ltd
What is Lanzhou Institute of Biological Products Co., Ltd's pipeline?
Lanzhou Institute of Biological Products Co., Ltd has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Botulinum Toxin Type A for Injection.
Related
- Sector hub: All tracked pharma companies